Evolution of the health benefits of soy isoflavones

Proceedings of the Society for Experimental Biology and Medicine

Volumn 217, Issue 3, 1998, Pages 386-392

  Barnes, Stephen ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BETA GLUCOSIDASE; BIOFLAVONOID; CHOLESTEROL; CYANOCOBALAMIN; DAIDZEIN; EQUOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; GENISTEIN; GLUCOSIDE; HIGH DENSITY LIPOPROTEIN; IPRIFLAVONE; ISOFLAVONE DERIVATIVE; ISOFLAVONOID; POLYPHENOL DERIVATIVE; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; ARTIFICIAL MILK; CANCER RISK; CARDIOVASCULAR DISEASE; DIET; ESTROGEN ACTIVITY; EVOLUTION; HEALTH; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; SOYBEAN;

GLYCINE MAX;

EID: 0031936521     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44249     Document Type: Article

References (75)

1. Harborne JB, Mabry TJ. The Flavonoids. London: Chapman & Hall, 1988.
2. Harborne JB. Nature, distribution, and function of plant flavonoids. Prog Clin Biol Res 213:15-24, 1986.
3. Parniske M, Ahlborn B, Werner D. Isoflavonoid-inducible resistance to the phytoalexin glyceollin in soybean rhizobia. J Bact 173:3432-3439, 1991.
4. Baker ME. Evolution of regulation of steroid-mediated intercellular communication in vertebrates: Insights from flavonoids, signals that mediate plant-rhizobia symbiosis. J Steroid Biochem Mol Biol 41:301-308, 1992.
5. Smit G, Puvanesarajah V, Carlson RW, Barbour WM, Stacey G. Bradyrhizobium japonicum nodD1 can be specifically induced by soybean flavonoids that do not induce the nodYABCSUIJ operon. J Biol Chem 267:310-318, 1992.
6. Barbour WM, Hattermann DR, Stacey G. Chemotaxis of Bradyrhizobium japonicum to soybean exudates. Appl Environ Microbiol 57:2635-2639, 1991.
7. Cunningham S, Kollmeyer WD, Stacey G. Chemical control of interstrain competition for soybean nodulation by Bradyrhizobium japonicum. Appl Environ Microbiol 57:1886-1892, 1991.
8. Lerouge P, Roche P, Faucher C, Maillet F, Truchet G, Promé J-C, Dénairié J. Symbiotic host-specificity of Rhizobium meliloti is determined by a sulphated and acetylated glucosamine oligosaccharide signal. Nature (London) 344:781-788, 1990.
9. Spaink HP, Sheeley DM, Van Brussel AAN, Glushka J, York WS, Tak T, Geiger O, Kennedy EP, Reinhold VN, Lugtenberg BJJ. A novel highly unsaturated fatty acid moiety of lipo-oligosaccharide signals determines host specificity of Rhizobium. Nature (London) 354:125-130, 1991.
10. Coward L, Barnes NC, Setchell KDR, Barnes S. The antitumor isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. J Agric Food Chem 41:1961-1967, 1993.
11. Kudou S, Fleury Y, Welti D, Magnolato D, Uchida T, Kitamura K, Okubo K. Malonyl isoflavone glycosides in soybean seeds (Glycine max MERRILL). Agric Biol Chem 55:2227-2233, 1991.
12. Wang H-J, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666-1673, 1994.
13. Barnes S, Kirk M, Coward L. Isoflavones and their conjugates in soy foods: Extraction and analysis by HPLC-mass spectrometry. J Agric Food Chem 42:2464-2474, 1994.
14. Adolph WH, Kiang PC. The nutritional value of soy bean products. China Med J 34:268-275, 1920.
15. Paino J, Messinger L. Tofu in Time: the History of Tofu. In: The Tofu Book: The New American Cuisine. Garden City Park, NY: Avery Publishing Group Inc., pp1-14, 1991.
16. Friedenwald J, Ruhrah J. The use of the soy bean as a food in diabetes. Am J Med Sci 140:793-803, 1910.
17. Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 12:141-146, 1922.
18. Kunitz M. Crystallization of a trypsin inhibitor from soybean. Science 101:668-669, 1945.
19. Young VR. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc 91:828-835, 1991.
20. Messina M, Barnes S. Workshop report from the Division of Cancer Etiology, National Cancer Institute, National Institutes of Health. The role of soy products in reducing risks of certain cancers. JNCI 83:541-546, 1991.
21. Hamilton RMG, Carroll KK. Plasma cholesterol levels in rabbits fed low-fat, low-cholesterol diets: Effects of dietary proteins, carbohydrates, and fibre from different sources. Atherosclerosis 24:47-62, 1976.
22. Sitori CR, Agradi E, Conti F, Mantero O, Gatti E. Soybean-protein diet in the treatment of type-II hyperlipoproteinemia. Lancet i:275-277, 1977.
23. Bakhit RM, Klein BP, Essex-Sorlie D, Ham JO, Erdman JW, Potter SM. Intake of 25 g soy protein reduces plasma cholesterol in men with elevated cholesterol concentrations. J Nutr. 124:213-222, 1994.
24. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. New Engl J Med 333:276-282, 1995.
25. Siddiqui MT, Siddiqui M. Hypolipidemic principles of Cicer Arietnum: biochanin A and formononetin. Lipids 11:243-246, 1976.
26. Clarkson TB, Anthony MS, Williams JK, Honore EK, Cline JM. The potential of soybean phytoestrogens for postmenopausal replacement therapy. Proc Soc Exp Biol Med 217:000-000.
27. Messina M, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer 21:113-131, 1994.
28. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and multi-drug resistance gene product. Biochem Biophys Res Commun 179:661-667, 1991.
29. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res 52:6200-6208, 1992.
30. Peterson G, Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells in culture but not epidermal growth factor receptor tyrosine phosphorylation. The Prostate 22:335-345, 1993.
31. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit breast tumor in models of breast cancer. In: Pariza MW, Aeschbacher H-U, Felton JS, Sato S, Eds. Mutagens and Carcinogens in the Diet. New York: Wiley-Liss, pp239-253, 1990.
32. Hawrylewicz EJ, Huang HH, Blair WH. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 121:1693-1698, 1991.
33. Barnes S, Peterson TG, Grubbs C, Setchell KDR. Potential Role of Dietary Isoflavones in the Prevention of Cancer. In: Diet and Cancer: Markers, Prevention, and Treatment. Jacobs M, Ed. New York: Plenum Press, pp.135-148, 1994.
34. Lamartiniere CA, Moore J, Holland M, Barnes S. Genistein and chemoprevention of breast cancer. Proc Soc Exp Biol Med 208:120-123, 1995.
35. Lamartiniere CA, Moore JB, Brown NA, Thompson RA, Hardin MJ, Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis 16:2833-2840, 1995.
36. Brown NM, Lamartiniere CA. Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Perspect 103:708-713, 1995.
37. Dhom G. Epidemiological aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res & Clin Oncol 106:210-218, 1983.
38. Donn AS, Muir CS. Prostatic cancer: Some epidemiological features. Bulletin du Cancer 72:381-390, 1985.
39. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63:963-969, 1991.
40. Clark AP, Schuttinga JA. Targeted estrogen/progesterone replacement therapy for osteoporosis: Calculation of health care cost savings. Osteoporosis International 2:195-200, 1992.
41. Shapiro S, Kelly JP, Rosenberg L, Kaufman DW, Helmrich SP, Rosenshein NB, Lewis JL, Knapp RC, Stolley PD, Schottenfield D. Risk of localized and widespread endometrial cancer in relation to current and discontinued use of oral contraceptives. N Engl J Med 313:969-972, 1985.
42. Agnusdei D, Adami S, Cervetti R, Crepaldi G, Di Munno O, Fantasia L, Isaia GC, Letizia G, Ortolani S, Passeri M, et al. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis. Bone & Mineral 19 (Suppl 1):S43-S48, 1992.
43. Nakamura S, Morimoto S, Takamoto S, Onishi T, Kukuo K, Koh E, Kitano S, Miyashita Y, Yasuda O, Tamatani M, et al. Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females. Calcified Tissue International 51(Suppl 1):S30-S34, 1992.
44. Brandi ML. Flavonoids: Biochemical effects and therapeutic applications. Bone Miner (Suppl) 19:S3-S19, 1992.
45. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effect of tyrosine kinase inhibitors on avion osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 60:1761-1769, 1996.
46. Irvine C. The phytoestrogen content of soy-based infant foods. Proc Soc Exp Biol Med 217:000-000.
47. Shemesh M, Lindner HR, Ayalon N. Affinity of rabbit uterine oestradiol receptor for phytoestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. J Reprod Fert 29:1-9, 1972.
48. Mathieson RA, Kitts WD. Binding of phyto-estrogen and oestradiol-17 by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocr 85:317-325, 1980.
49. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103:1860-1867, 1978.
50. Shutt DA, Cox RI. Steroid and phyto-estrogen binding to sheep uterine receptors in vitro. J. Endocr 52:299-310, 1972.
51. Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 β-estradiol: Comparison with conventional oral estrogens used for hormone treatment. Am J Obstet Gynecol 152:1099-1106, 1985.
52. Mashchak CA, Lobo RA, Dozono-Takano R, Eggena P, Nakamura RM, Brenner PF, Mishell DR Jr. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 144:511-518, 1982.
53. Walsh BW, Sacks FM. Effects of postmenopausal hormone replacement therapy with oral and transdermal estrogen on high density lipoprotein metabolism. J Lip Res 35:2083-2093, 1994.
54. Barnes S, Sfakianos J, Coward L, Kirk M, Peterson GP. Soy isoflavonoids and cancer prevention: Underlying biochemical and pharmacological issues. In: Dietary Phytochemicals and Cancer Prevention. Butrum R, Ed. New York: Plenum Press, pp87-100, 1996.
55. Farmakalidis E, Murphy PA. Isolation of 6′-O-acetyldaidzein and 6′-O-acetylgenistein from toasted defatted soy flakes. J Agric Food Chem 33:385-389, 1985.
56. Cruz ML, Wong WW, Mimouni F, Hachey DL, Setchell KDR, Klein PD, Tsang RC. Effects of infant nutrition on cholesterol synthesis rates. Pediat Res 35:135-140, 1994.
57. Sfakianos J, Coward L, Kirk M, Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127:1260-1268, 1997.
58. Adlercreutz H, Fotsis T, Lampe J, Wähälä K, Mäkelä T, Brunow G, Hase T. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest 53(Suppl 215):5-18, 1993.
59. Onishi S, Kawade N, Itoh S, Isobe K, Sugiyama S. Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J 184:705-707, 1979.
60. Wang CF, Kurzer MS. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28:236-247, 1997.
61. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27:31-40, 1997.
62. Peterson TG, Barnes S. Genistein inhibits both estrogen and growth factor stimulated proliferation of human breast cancer cells. Cell Growth Diff 7:1345-1351, 1996.
63. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci (USA) 93:5925-5930, 1996.
64. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-I, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987.
65. Hunter T, Cooper JA. Role of tyrosine phosphorylation in malignant transformation by viruses and in cellular growth control. Prog Nucl Acid Res Mol Biol 29:221-232, 1983.
66. Powis G, Kozikowski A. Growth factor and oncogene signalling pathways as targets for rational anticancer drug development. Clin Biochem 24:385-397, 1991.
67. Peterson TG. Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125:784S-789S, 1995.
68. Barnes S, Peterson TG, Coward L. Use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem 22:181-187, 1995.
69. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90:2690-2694, 1993.
70. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918-924, 1995.
71. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murell J, McCormick MK, Pericak Vance MA, Heutinik P, Oostra BA, Haitjema T, Westerman CJ, Porteous ME, Guttmacher AE, Letarte M, Marchuk DA. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia. Nature Genetics 8:345-351, 1994.
72. Cheifetz S, Bellon T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M. Endoglin is a component of the transforming growth factor-β receptor system in endothelial cells. J Biol Chem 267:19027-19030, 1993.
73. Vincent P, Plaucha H, Hazan J, Faure S, Weissenbach J, Godet J. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Human Mol Gen 4:945-949, 1995.
74. Sadowska-Krowicka H, Mannick E, Oliver PD, Sandoval M, Zhang X-J, Eloby-Childress S, Clark DA, Miller MJS. Genistein and gut inflammation: Role of nitric oxide. Proc Soc Exp Biol Med 217:351-357, 1998.
75. The Dictionary of Traditional Chinese Medicine. Edited by Jian Su Medical College. Shanghai, China: Shanghai Scientific and Technology Publishers, pp 2382-2383, 1977.